Bluestem Biosciences Inc.
Omaha, NE
- UEI
- GWTCKKY5TUN6
- CAGE
- 9UE59
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 3555 Farnam St #12, Omaha, NE 68131, USA
- Website
- bluestembiosciences.com
- Founded
- 2022
- Employees
- 11-50
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Grant awards
Grant subawards
| Prime recipient | Prime award | Amount | Awarded |
|---|---|---|---|
| Bioindustrial Manufacturing And Design Ecosystem | FA86502125028 | $547,701 |
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Zymochem Inc. | San Leandro, CA | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
| Lakril Technologies Corporation | Chicago, IL | — |
| Resource Chemical Corp | Palo Alto, CA | — |
| Phaxtec, Inc. | Wake Forest, NC | 325211 Plastics Material and Resin Manufacturing |
| Superbrewed Food Inc. | New Castle, DE | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
About the company
Bluestem Biosciences Inc. is a for-profit biotechnology company based in Omaha, Nebraska, specializing in advanced biomanufacturing technologies and innovative microbial engineering solutions. The company focuses on developing sustainable chemical production methods, particularly in the realm of anaerobic fermentation and yeast microbe modification to create alternative, bio-based chemical intermediates. Registered in SAM.gov since June 2022, Bluestem Biosciences has positioned itself as a key player in transforming traditional petrochemical production processes through biotechnological innovations.
The company has secured multiple significant federal grants from agencies including the National Science Foundation, U.S. Department of Agriculture's Rural Housing Service, and the Department of Energy's Office of Science. These grants, totaling over $11.3 million, are primarily focused on developing advanced biomanufacturing technologies centered on producing 3-hydroxypropionic acid (3-HP), a critical chemical intermediate for creating acrylic-based materials. Their research targets creating cost-effective, domestically produced chemical ingredients using renewable sources like corn feedstock, with a broader impact of reducing greenhouse gas emissions, supporting rural economic development, and establishing more resilient supply chains. Bluestem Biosciences has also engaged in sub-grant collaborations with the Bioindustrial Manufacturing And Design Ecosystem, working on projects related to bio-acrylics, organic acid separations, and innovative fermentation techniques. The company's work spans multiple grant phases, including SBIR Phase I and Phase II projects, demonstrating a strategic approach to developing and commercializing sustainable biotechnological solutions.
Quick answers
Is Bluestem Biosciences Inc. registered in SAM.gov?
Yes. Bluestem Biosciences Inc.'s SAM.gov registration is active through July 28, 2027.
What is Bluestem Biosciences Inc.'s most recent federal award?
Bluestem Biosciences Inc.'s most recent federal grant award is Sbir phase II: anaerobic biomanufacturing of 3-hydroxypropionic acid utilizing whole-kernel corn feedstock (2535156), from National Science Foundation, on October 1, 2025.
On GovTribe
See Bluestem Biosciences Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors